Gaze Holding in Cerebellar Patients

Sponsor
University of Zurich (Other)
Overall Status
Completed
CT.gov ID
NCT02185313
Collaborator
(none)
22
1
1
76
0.3

Study Details

Study Description

Brief Summary

The long-term goal of this research is to advance the investigators knowledge of how the cerebellum a) controls gaze holding and compensates for impaired gaze stability and b) modulates vestibular information that is forward-ed from the labyrinth and brought to perception. While gaze holding is stable also at large angles of gaze eccentricity in healthy human subjects, patients with chronic (degenerative) cerebellar disorders are inable to stabilize gaze in eccentric positions, resulting in eye drift towards primary (straight-ahead) position and com-pensatory gaze-evoked nystagmus. When returning to primary position, a compensatory nystagmus into the opposite direction (called rebound nystagmus) can be observed in these patients. Unlike patients with de-generative cerebellar disorders, patients suffering from ischemic of hemorrhagic stroke within the cerebellum present with acute deficits of gaze holding and verticality perception.

While a linear relationship between the amount of eye velocity drift and eccentricity of eye position has been proposed in healthy human subjects, others suggested non-linear behaviour. The strategy of this research is to characterize gaze holding and verticality perception in healthy human subjects and patients with either acute (ischemic or hemorrhagic) or chronic degenerative cerebellar disorders and to relate eye movement findings with structural imaging of the cerebellum. The investigators will therefore analyze key cerebellar structures with regards to loss of volume and relate these imaging findings with the participants' ability to hold gaze and es-timate direction of vertical. The investigators hypothesize that besides the flocculus other vestibulo-cerebellar structures are involved in gaze holding and verticality perception in humans.

Condition or Disease Intervention/Treatment Phase
  • Other: visual stimulus to follow
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
22 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Verticality Perception and Gaze Holding in Healthy Human Subjects and Patients With Acute and Chronic Cerebellar Disorders
Actual Study Start Date :
Aug 1, 2013
Actual Primary Completion Date :
Nov 30, 2019
Actual Study Completion Date :
Nov 30, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: gaze holding

Other: visual stimulus to follow

Outcome Measures

Primary Outcome Measures

  1. eye velocity in relation to eye position [during the visual stimulus (5min)]

Secondary Outcome Measures

  1. symmetry of eye velocity for right vs. left gaze [during the visual stimulus (5min)]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. ages 18-85

  2. informed consent

  3. for group 1: acute (i.e. symptom onset <14 days ago) cerebellar ischemia or hemorrhage as confirmed by clinical examination and brain imaging (CT or MRI)

  4. for group 2: chronic cerebellar degeneration as confirmed by clinical examination (presence of downbeat-nystagmus and / or gaze-evoked nystagmus and / or ataxia of gait and stance) in the absence of focal lesions (as previous cerebellar stroke, mass lesion or inflammation) on clinical routine cerebellar imaging

  5. absence of exclusion criteria

Exclusion Criteria:
  1. has MRI contraindications such as pacemaker, implanted pumps, shrapnel, etc. (full MRI screening form will be filled out).

  2. disturbed consciousness

  3. other neurological or systemic disorder which can cause dementia or cognitive dysfunction

  4. Pregnancy or possible pregnancy if not ruled out by a negative pregnancy test.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital Zurich, Division of Neurology Zurich ZH Switzerland 8091

Sponsors and Collaborators

  • University of Zurich

Investigators

  • Principal Investigator: Dominik Straumann, Prof MD, University Hospital Zurich, Division of Neurology

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Zurich
ClinicalTrials.gov Identifier:
NCT02185313
Other Study ID Numbers:
  • gaze_holding_cerebellar_zurich
First Posted:
Jul 9, 2014
Last Update Posted:
Jan 7, 2020
Last Verified:
Dec 1, 2019

Study Results

No Results Posted as of Jan 7, 2020